{"id":"NCT03500549","sponsor":"Apellis Pharmaceuticals, Inc.","briefTitle":"Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)","officialTitle":"A Phase III, Randomized, Multi-Center, Open-Label, Active-Comparator Controlled Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-06-14","primaryCompletion":"2019-11-14","completion":"2020-08-13","firstPosted":"2018-04-18","resultsPosted":"2022-03-25","lastUpdate":"2022-03-25"},"enrollment":80,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Paroxysmal Nocturnal Hemoglobinuria"],"interventions":[{"type":"DRUG","name":"Pegcetacoplan","otherNames":["APL-2"]},{"type":"DRUG","name":"Soliris","otherNames":[]}],"arms":[{"label":"Pegcetacoplan","type":"EXPERIMENTAL"},{"label":"Eculizumab","type":"ACTIVE_COMPARATOR"}],"summary":"Evaluation of the Efficacy and Safety of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria","primaryOutcome":{"measure":"Least Squares (LS) Mean Change From Baseline to Week 16 in Hemoglobin (Hb) Level During the RCP","timeFrame":"Baseline and Week 16","effectByArm":[{"arm":"Pegcetacoplan to Pegcetacoplan","deltaMin":2.37,"sd":0.363},{"arm":"Eculizumab to Pegcetacoplan","deltaMin":-1.47,"sd":0.666}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":15},"locations":{"siteCount":53,"countries":["United States","Australia","Belgium","Canada","France","Germany","Japan","Russia","South Korea","Spain","United Kingdom"]},"refs":{"pmids":["40720060","40285403","39079163","38727860","38593241","37707673","36055332","35869984","35796199","34445916","33730455"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":80},"commonTop":["Injection site erythema","Diarrhoea","Headache","Haemolysis","Fatigue"]}}